20.4 C
New York
Thursday, June 18, 2026

Tag: interim

Franco-Nevada Reports Record Q2 2025 Results

Acquisitions Increase Growth Outlook (in U.S. dollars unless otherwise noted) TORONTO, Aug. 9, 2025 /PRNewswire/ - "I am very pleased with our record financial results this...

Everest Medicines to Announce 2025 Interim Results on August 29, 2025

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and...

Everest Medicines to Announce 2025 Interim Results on August 29, 2025

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and...

Diversified Energy Announces Second Quarter Dividend

Announces Second Quarter 2025 Dividend

AS Tallinna Sadam financial results for 2025 Q2 and 6 months

In the second quarter, Tallinna Sadam earned close to 30 million euros in sales revenue and more than 3 million euros in profit. The revenue for six months was 58 million euros and the profit exceeded 10 million euros. In the second quarter, the volume of investments increased to 8 million euros, in the first half of the year we invested a total of 12 million euros.

Dorel Reports Second Quarter 2025 Results

MONTRÉAL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Dorel Industries Inc. (TSX: DII.B, DII.A) today announced its financial results for the second quarter and six months ended June 30, 2025.

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and nine months ended June 30, 2025 and provided an update on its business.

Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy-Back Programme

Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy-Back Programme

Salama Announces Robust H1 2025 Performance Driven by Profitability and Equity Growth

H1 2025 net profit stands at AED 8.25 million driven by profits of AED 7.86 million in the second quarter of 2025Improved equity position...

Salama Announces Robust H1 2025 Performance Driven by Profitability and Equity Growth

H1 2025 net profit stands at AED 8.25 million driven by profits of AED 7.86 million in the second quarter of 2025Improved equity position...

Clarke Inc. Reports Refinancing of Credit Facilities and 2025 Second Quarter Results

HALIFAX, NS, Aug. 8, 2025 /CNW/ - Clarke Inc. ("Clarke" or the "Company") (TSX: CKI) today announced its results for the three and six...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInterim